NeoGenomics, Inc. (NEO)
NASDAQ
Closed
Oct 9, 2026
Day's Range
16.0052 wk Range
7.07Overview - NEO - NeoGenomics, Inc.
Key Statistics
Valuation
Enterprise Value
2.66B
P/E (Trailing)
‪-23.01‬
P/E (Forward)
‪54.29‬
PEG Ratio
‪0.21‬
Price / Sales (TTM)
‪3.07‬
Price / Book
‪2.98‬
EV / EBITDA
‪109.42‬
Profitability
Gross Margin
‪45.56%‬
Profit Margin
‪-6.77%‬
Operating Margin
‪-4.84%‬
Return on Assets
‪-1.88%‬
Return on Equity
‪-6.32%‬
Ownership
Shares Outstanding
127.91M
Float
117.01M
Short % of Shares Outstanding
‪14.47%‬
Held by Insiders
‪2.10%‬
Held by Institutions
‪115.23%‬
Price stats
Beta
‪1.74‬
50-Day Avg
‪16.59‬
200-Day Avg
‪12.08‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
12 analysts
Average price target
‪$ 19.72‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NEO - NeoGenomics, Inc.
Peers - NEO - NeoGenomics, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- NEONASDAQNeoGenomics, Inc.2.48BMarket Cap+58.98%52-week change-23.01P/E (Trailing)‪-6.77%‬Profit Margin
- NTRANASDAQNatera, Inc.59.14BMarket Cap+58.48%52-week change-269.84P/E (Trailing)‪-7.10%‬Profit Margin
- ILMNNASDAQIllumina Inc.41.22BMarket Cap+63.00%52-week change50.85P/E (Trailing)‪18.33%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.40.83BMarket Cap-21.10%52-week change37.14P/E (Trailing)‪25.03%‬Profit Margin
- GHNASDAQGuardant Health Inc.23.86BMarket Cap+64.35%52-week change-53.55P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings, Inc.16.86BMarket Cap+14.16%52-week change35.48P/E (Trailing)‪17.66%‬Profit Margin
- ICLRNASDAQICON plc12.50BMarket Cap-17.51%52-week change170.58P/E (Trailing)‪0.32%‬Profit Margin
Profile Summary - NEO - NeoGenomics, Inc.
About
NeoGenomics, Inc. is a cancer diagnostics company focused on oncology testing and information services. The company provides a broad menu of laboratory solutions across the cancer care continuum, including molecular testing, next-generation sequencing, fluorescence in situ hybridization, flow cytometry,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
